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A B S T R A C T
This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows:
To determine the accuracy of general practitioners’ overall gestalt (unaided) clinical judgement for diagnosing cognitive impairment
and dementia in symptomatic people presenting to primary care. There is no comparator index test.
To investigate the heterogeneity of test accuracy in the included studies.
B A C K G R O U N D
Cochrane is undertaking a series of reviews investigating the diag-
nostic accuracy of a variety of tests for diagnosing dementia, but to
contextualise the findings to practice it is also important to quan-
tify the accuracy of clinical judgement. Doctors use a variety of
processes to reach a diagnosis, including non-analytical reasoning
processes such as pattern recognition, to rapidly generate diagnos-
tic hypotheses (Norman 2007; Elstein 2009). Some people with
dementia unfortunately have sufficiently advanced disease at the
point of diagnosis that additional tests may be unnecessary and
burdensome. General practitioners (GPs) often report using their
clinical judgement, rather than a formal test, to determine whether
someone has dementia (O’Connor 1993; Pentzek 2009). A review
of the clinical judgement of GPs is therefore an important step in
determining the potential added value of more formal diagnostic
workup, such as brief cognitive tests.
Target condition being diagnosed
In this protocol we investigate the accuracy of gestalt clinical judge-
ment for the diagnosis of two target conditions: all-cause demen-
tia, and cognitive impairment due to dementia or mild cognitive
impairment (MCI).
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Dementia is a clinical syndrome of cognitive impairment that
develops gradually and causes a decline in functioning. Dementia
is increasingly common with age, affecting less than 5% of the
population aged less than 75 years and 17% of those aged over
89 years (Matthews 2013). Dementia may result from a variety
of pathologies, but in the elderly population in the community
these subtype definitions based on disease aetiology are thought
by some investigators to be of less relevance, as most old people
with dementia have mixed pathology at autopsy (Neuropathology
2001; Savva 2009; Brayne 2012; Kawas 2015).
Cognitive impairment includes dementia and MCI (Gauthier
2006). MCI is a syndrome of cognitive impairment that is greater
than expected when accounting for a person’s age and educational
attainment, but that does not interfere with capacity for indepen-
dence in everyday activities of daily living. MCI affects between
3% and 20% of adults aged over 65 years (Gauthier 2006), and
the prognosis in general practice is variable: approximately 25%
of people develop dementia within three years but around 40%
revert to normal (Kaduszkiewicz 2014).
Experience in clinical general practice is that when there are con-
cerns about impaired cognition these are focused primarily on the
possibility of dementia rather thanMCI, but inevitably some peo-
ple who are evaluated for possible dementia will be diagnosed with
MCI. In this protocol we include people who are ultimately diag-
nosed as having MCI when we refer to a person consulting with
a GP about possible dementia (e.g. under Participants or Clinical
pathway), because it would be unusual for a person to consult a
GP about possible MCI or cognitive impairment. Our second tar-
get condition includes both dementia and MCI because it would
be unusual for a GP to diagnose MCI, especially on the basis of
gestalt judgement alone, because neuropsychological evaluation is
often required. If gestalt clinical judgement was sensitive for any
cognitive impairment, then if the GP assessed the person as being
cognitively normal it would rule out both dementia and MCI.
Index test(s)
The index test will be a clinical diagnosis of cognitive impairment
(due to MCI or dementia), or dementia, based on the overall clin-
ical judgement (or gut feeling/gestalt (Lehman 2015)) of a pri-
mary care physician after a clinical assessment, unaided by formal
(even brief ) cognitive tests. We operationalise this as a single index
test (clinical judgement) with two target conditions (see Target
condition being diagnosed for details). Diagnostic labels in general
practice may function primarily to guide the management of the
patient, to treat, to investigate, or to exclude serious disease (Jones
2010). GPs have been described as using intuition (Barraclough
2006; Woolley 2013), pattern recognition (Heneghan 2009) and
scripts (Charlin 2000), amongst other strategies (Heneghan 2009),
to reach a diagnosis.
The diagnostic accuracy of GPs’ clinical judgment about the pres-
ence of dementia after consulting with patients had good diag-
nostic accuracy (sensitivity 92%, specificity 76%) in one study
(Cooper 1992). This compared fairly well to the diagnostic accu-
racy of the informant questionnaire for cognitive disorders in the
elderly (IQCODE), a brief cognitive test for diagnosing dementia,
at a cutpoint of 3.2 (sensitivity 100%, specificity 76%) (Harrison
2014) and, in a different clinical context, to the clinical judgement
of GPs regarding the severity of chest pain aetiology based only on
brief history and examination (sensitivity 82%, specificity 79%)
(Buntinx 1991). GPs report lack of time as a barrier to diagnosing
dementia (Koch 2010) and report often relying on personal ob-
servations to make the diagnosis (O’Connor 1993) whereas pen-
and-paper tests are used by a minority of people (Pond 2013).
Clinical pathway
Prior tests
Many people who are concerned about the onset of possible de-
mentia present to a healthcare provider for an evaluation; often
the first consultation would be with a primary care provider (com-
monly a GP) but in some health economies the first consultation
may be with a specialist clinician. Some people may not experi-
ence subjective cognitive problems (Waldorff 2012), but may be
encouraged (or taken) to attend a consultation with a clinician by
a close contact (e.g. a carer) or professional who is concerned about
possible dementia. A further possibility is that a GP may form an
impression of possible cognitive impairment during a consultation
with a patient about a (potentially) unrelated matter.
Most commonly in research studies and clinical practice, no tests
would be performed before a GP consultation regarding possible
dementia. Some people may consult with their GP about the pos-
sibility of dementia after performing a self-administered cognitive
test such as test-your-memory (Brown 2009). Alternatively some
people might have been asked to see their GP as a consequence
of undergoing brief cognitive testing conducted by another health
professional (for example, a district nurse or hospital doctor), or
as part of a research project.
In this review we will only consider clinical judgement by a pri-
mary care physician (GP) in someone who is considered to have
symptoms. Either the patient themselves or someone else, includ-
ing a health professional (including the consulting GP), should be
concerned about possible cognitive impairment. Recent policy in
the USA and UK has encouraged screening for dementia in peo-
ple who do not have symptoms (Burns 2013; Rasmussen 2013;
Rasmussen 2014). This remains controversial (Brayne 2007; Fox
2013; Le 2013; Iliffe 2014) and we do not propose to include
these people in this review.
Role of index tests
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It is rare that any single component of a diagnostic evaluation
would be diagnostic for a condition by itself. Most people who
are being evaluated for possible cognitive impairment or dementia
will commonly undergo further assessment that may include brief
cognitive tests and investigations such as biochemical analysis and
neuroimaging. Most commonly in primary care, further assess-
ment of a patient is dependent on the GPs’ clinical judgment:
when the GP feels comfortable to exclude cognitive impairment
or dementia without further assessment the patient will usually
undergo no further tests, whereas when the GP feels uncertain
then further evaluation may be arranged. It would be unusual for
a GP to rule-in dementia without further assessment, but this may
occur when the patient is frail, affected by multiple comorbidities,
and perhaps resident in a nursing home, where the prior probabil-
ity of dementia (or prevalence) may be as high as 60% (Magaziner
2000), and when the management may be primarily palliative.
In some situations GPs may use a test of time (Almond 2009)
to help increase the specificity of a diagnosis, especially when the
condition may fluctuate, and a GP may therefore form a ’working
diagnosis’, which is reviewed over a period of time, before deciding
on a formal recorded diagnosis.
Alternative test(s)
Alternatives to the index test would include a more detailed eval-
uation, which may be conducted by a specialist, and might in-
clude aspects of clinical history, examination, cognitive testing,
biochemical and haematological analysis and neuroimaging.
Rationale
A systematic review published in 2010 found that the judgement
of GPs was highly specific for diagnosing dementia at all stages of
severity, but only moderately sensitive (van den Dungen 2012). A
second review addressing a similar question used a more restricted
search strategy (Mitchell 2011). Both reviews were well conducted
but allowed a broad definition of ’clinical judgement’ that is not
immediately applicable to clinical practice, by including studies
where ’clinical judgement’ was defined as a documented diagnosis
in the medical records, which may not accurately reflect the ac-
tual clinical opinion (Russell 2013). Additionally, there is scope
to develop the search strategy, in particular to include more terms
relating to dementia, cognitive impairment and diagnostic accu-
racy.
O B J E C T I V E S
To determine the accuracy of general practitioners’ overall gestalt
(unaided) clinical judgement for diagnosing cognitive impairment
and dementia in symptomatic people presenting to primary care.
There is no comparator index test.
Secondary objectives
To investigate the heterogeneity of test accuracy in the included
studies.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include cross-sectional studies (where participants have
index test and reference test at the same encounter, which would
be unusual) and cohort studies. We recognise that cross-sectional
studies might be at higher risk of incorporation bias than cohort
studies and we will account for this when we assess studies for risk
of bias (quality appraisal); we judge that the alternative approach
of excluding cross-sectional studies would be too restrictive. We
will not include case-control studies because they are at high risk
of bias and because, by definition, any participants would have
been recruited on the basis of disease state (dementia, cognitive
impairment or normal). This would prevent GPs from making a
blinded gestalt clinical judgement about the diagnosis, because in
most health systems the GP primary care record contains entries
relating to all medical and psychiatric diagnoses, which would
include cognitive impairment and dementia.
Participants
We will only include studies that have recruited participants from
primary care. We define primary care as first-contact health care
provided by a non-specialist clinician in a continuing-care office
setting.Wewill exclude studies where the consultation with a non-
specialist takes place in hospital (including outpatients or emer-
gency departments) as this is unlikely to represent primary care
in the sense that is relevant to our review. Because we anticipate
that reporting in original studies may be suboptimal (Noel-Storr
2014), we will include studies where some or all of the participants
are consulting with a primary care provider about possible demen-
tia following a recommendation by a non-specialist secondary care
provider (e.g. emergency department), even if the study does not
explicitly state these people were consulting secondary care about
a non-dementia concern (e.g. a fall).
We will only include studies where GPs make a clinical judgement
about the presence or absence of cognitive impairment or demen-
tia in someone who is suspected of having it (either by the patient,
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a caregiver, or professional - including the consulting GP).Wewill
exclude studies where GPs are asked to make a judgement about
the presence or absence of cognitive impairment or dementia in all
people attending primary care, regardless of the reason for atten-
dance, as this is akin to screening. We recognise that other primary
care providers might form clinical judgements about the possibil-
ity of cognitive impairment, but we will only include studies that
use GPs as the primary care provider because we are concerned
that including other professionals would introduce even greater
heterogeneity than we already anticipate; for instance, although
GPs are required to hold a license to practice medicine, the train-
ing requirements and scope of practice may vary substantially in
different countries.
Index tests
We propose that the core feature of clinical judgement is that it
is unaided by any additional test, investigation or inquiry beyond
that which is immediately available to the clinician (Blaeuer 2013;
Di 2013; Body 2014). As outlined above, in this review we are
investigating a single index test (clinical judgement) with two tar-
get conditions (cognitive impairment composite or dementia). In
everyday practice, a clinical judgement is necessarily formed after
an encounter with a patient during which GPs would often have
access to the medical record and might review this in conjunction
with meeting the patient. There are three ways that clinical judge-
ment (for research) may be used in a diagnostic accuracy study
in general practice. The first definition is a documented diagnosis
of cognitive impairment or dementia in the medical records; we
consider that this definition reflects the process of documentation
rather than clinical judgement. The second definition is a judge-
ment of a clinician based on knowledge of the patient and review
of the medical notes, but not relating to a specific encounter with
the patient; we consider that this definition reflects consulting be-
haviour of people (in this case with cognitive impairment or de-
mentia). The third definition is a clinical impression formed by
the clinician after consulting with a patient who has presented
to a specific encounter with the doctor (perhaps with symptoms
suggestive of possible dementia, though not always - because it
may be the consulting GP who raises the possibility of cognitive
problems), and we consider this to be the definition of clinical
judgement that is most relevant to practice. For this review, we
will include studies that use the third definition (clinical impres-
sion after consultation) but we anticipate that there will be very
few studies that use this design. Therefore, to avoid an empty re-
view, we will also include studies that use the second definition
(based on existing knowledge of the patient and not relating to
a particular encounter) so long as the index test (GP judgement
about cognitive impairment or dementia) has taken place before
any definitive diagnosis (for example, specialist assessment in a
memory clinic). We will investigate the use of medical records as
a source of heterogeneity under the category ’prior tests’ for any
study that allows doctors access to the medical records, regardless
of whether clinical judgement is defined using definition two or
three. For studies that use definition two it will usually be explicit
that GPs were allowed to review the medical record, but if this
is not clear we will always make the assumption that the records
were reviewed.Wewill judge that access to themedical records was
allowed for studies that use definition three only if this is explicit.
The doctor’s clinical impression will often determine the extent of
the additional work-up offered. In one scenario, people who are
thought to be highly likely to have dementia might have only a
brief ’rule-in’ test together with blood tests to exclude other causes
such as hypothyroidism or infection, or (rarely) no additional tests
at all; this scenario is less applicable to people who are thought
to have cognitive impairment rather than frank dementia. In a
second scenario, where there is a degree of uncertainty, people
might be referred to a specialist, and in a third scenario those who
are thought to be highly unlikely to have any problems might
be offered a brief ’rule-out’ test, or none at all. We will include
studies where some (but not all) participants undergo both the
index test and reference standard, so long as at least some index test
positives and index test negatives undergo the reference standard,
and will account for this verification bias using the QUADAS-2
checklist; for these studies we will use the population undergoing
both tests as the denominator for diagnostic accuracy and we will
document the prevalence of cognitive impairment and dementia
in the total sample separately. We will not exclude studies where
GPs are allowed to use additional cognitive tests to help determine
the management of the patient after formulating and expressing
their unaided judgement, but if we judge that these additional
tests have contributed to formulation of clinical judgement wewill
account for this as a source of heterogeneity as described below.
However, we will not evaluate the accuracy of any tests other than
clinical judgement in this review.
Original studies may offer GPs two (cognitive impairment, nor-
mal; or dementia, normal) or three possible diagnostic categories
(dementia, cognitive impairment, normal), and may ask GPs to
rate their confidence in the diagnosis, or how probable it is.
Impact of GP decision-making on further evaluation and
verification bias
If theGP judges that cognitive impairment or dementia is unlikely
and does not perform any further verification, but the person has
cognitive impairment or dementia, then this person would be a
false negative case; in this event prevalence of cognitive problems
will be underestimated, and estimated sensitivity will be higher
than the true value. In other cases GPs might suspect dementia
but not take any further action to confirm (with further tests)
or to document the diagnosis; in this event prevalence will be
underestimated and the estimated sensitivity and specificity would
both be affected (most likely theywill be underestimated but this is
impossible to determine). This second circumstance might occur
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if the doctor is not specifically asked about their judgement about
dementia after consultingwith patients, because in general practice
the specific diagnosis is often less important than the prognosis
and impact for the patient (Schellevis 2004). This is more likely
if the patient is predominantly burdened by some other physical
health problem and has an anticipated short life expectancy, so that
the purpose of confirming a dementia diagnosis may be unclear
(Slavin 2013). This situation is likely to be much more of an issue
for people with dementia than those with cognitive impairment.
Only research studies that offer a reference standard assessment to
all people presenting with concerns about cognitive impairment,
regardless of the GPs’ gestalt clinical judgement, will be able to
report robust data on diagnostic accuracy.
Target conditions
The first target condition is all-cause dementia. We will include
a diagnosis of dementia at any stage of disease, because we do
not want to restrict our results and this pragmatic approach is
most relevant to clinical practice. We will not examine the utility
of clinical judgement for risk prediction of future dementia. The
second target condition is cognitive impairment due to MCI or
dementia.
Reference standards
To allow for a pragmatic and sensitive approach to study inclu-
sion, we will include different reference standards (outlined be-
low). Studies must administer the index test and reference test
(excepting longitudinal follow up) within six months; if authors
do not provide details of this time interval we will include the
study and account for this as ’unclear’ in the quality appraisal us-
ing QUADAS-2.
Dementia
We will include studies that apply the reference standard of
all-cause dementia according to DSM (American Psychiatric
Association) or ICD (ICD 1993) definitions, regardless of ver-
sion. We will also include studies that use Agecat (Copeland
1986), CAMDEX (Roth 1986) and Clinical Dementia Rating
Scale (Hughes 1982) as the reference standard, as these are well-
validated methods of applying the aforementioned diagnostic cri-
teria. We will include studies that use expert specialist clinical
judgement as the reference standard. We consider a specialist to be
a clinician who has particular expertise in diagnosing and manag-
ing dementia, who will usually practice in a hospital, and have the
professional status of a geriatrician, psychiatrist or neurologist. We
will include studies that use longitudinal confirmation of the diag-
nosis of all-cause dementia in primary care, because we anticipate
that in some studies a specialist assessment will only be offered to
some participants. We operationalise ’longitudinal confirmation
of the diagnosis in primary care’ as case record review occurring
at least three months after the index test diagnosis of dementia
where no other alternative diagnosis is identified. It is likely that
many people who can be correctly diagnosed as having dementia
by unaided clinical judgement (true positives) would have a fairly
advanced stage of disease, but stage of disease will not form part
of the target condition.
Although the target condition is all-cause dementia we will also
include studies that use an aetiological sub-type definition: for
Alzheimer disease dementia (McKhann 1984; McKhann 2011),
vascular dementia (Román 1993), Lewy body dementia (McKeith
1996; McKeith 2005) or frontotemporal dementia (Neary 1994).
Cognitive impairment
Cognitive impairment is a composite target condition. We will
allow any recognised definition of MCI (Petersen 1999; Petersen
2004; Winblad 2004; McKhann 2011), as well as the reference
standards for dementia outlined above.
In addition to dementia and MCI there are other causes of cog-
nitive impairment, such as delirium and head injury, but these
are not part of the target condition that we are investigating in
this review. If the index tests indicated cognitive impairment or
dementia and further evaluation demonstrated that the clinical
problem was delirium instead, the test would be false positive.
Search methods for identification of studies
Electronic searches
We will search MEDLINE (OvidSP); Embase (OvidSP); BIOSIS
previews (ThomsonReutersWeb of Science);Web of ScienceCore
Collection, including the Science Citation Index and the Con-
ference Proceedings Citation Index (Thomson Reuters Web of
Science); PsycINFO (OvidSP), LILACS (BIREME) and ALOIS
(www.medicine.ox.ac.uk/alois). See Appendix 1 for the MED-
LINE search strategy. Where appropriate, we will use controlled
vocabulary such as MeSH terms (in MEDLINE) and EMTREE
(in Embase) and other controlled vocabulary in other databases,
as appropriate.
Search filters are collections of terms aimed at reducing the number
needed to screen by filtering out irrelevant records and retaining
only those that are relevant. We will not use search filters designed
to retrieve diagnostic test accuracy studies as a method to restrict
the search overall, because available filters have not yet proved
sensitive enough for systematic review searches (Whiting 2011a).
We will include a validated filter for primary care studies that
optimises sensitivity and specificity (Gill 2014). We will not apply
any language restriction to the electronic searches.
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Searching other resources
Wewill check the reference lists of all relevant papers for additional
studies. We will also search:
• meta-analyses van Diagnostisch Onderzoek (MEDION
database) (www.mediondatabase.nl);
• NIHR Dissemination Centre (which replaced DARE)
(discover.dc.nihr.ac.uk/portal);
• Health Technology Assessment Database (HTA Database)
in the Cochrane Library (www.cochranelibrary.com); and
• Aggressive Research Intelligence Facility (ARIF database)
(147.188.28.230/rmwp).
We will also talk to experts and attempt to contact authors where
necessary to obtain details of unpublished studies.
Data collection and analysis
Selection of studies
One review author will screen all retrieved titles for relevance and
classify titles as definitely relevant, possibly relevant and definitely
irrelevant; possibly relevant titles will be considered by a second
author to determine whether the abstract should be reviewed (de-
fault position) or not. Two authors will then assess all relevant ab-
stracts, resolving disagreements about whether to include an arti-
cle by discussion and by involving an arbiter where necessary. We
will attempt to retrieve any potentially eligible studies for full text
review.
If data froma study are presented inmultiple paperswewill present
this under a ’primary reference’ based on the study that provided
most data to our review, unless papers contribute similar amounts
of data, inwhich case wewill designate the primary reference based
on publication date of manuscripts. We will detail study selection
in a PRISMA flowchart. We will attempt to categorise reasons
for excluding articles at the full text stage under the following
hierarchy.
1. Inappropriate participants
i) Not primary care
ii) Index test not performed in someone where there is a
suspicion of dementia (i.e. a screening study)
2. Inappropriate reference standard
i) Not one of the specified reference standards
3. Inappropriate index test
i) Not GP
ii) Not gestalt clinical judgement
4. Inappropriate target condition
5. Inappropriate study design (i.e. not a diagnostic test
accuracy study e.g. a study reporting qualitative data, descriptive
epidemiology, randomised trial or survey)
Difficulties can arise in reviews of diagnostic accuracy as towhether
to include studieswhere informationondiagnostic accuracy on the
index test of interest might be available but is not reported. Table
1 shows the circumstances under which we will contact authors in
the hope of obtaining relevant information on diagnostic accuracy.
Data extraction and management
Wewill use a study specific pro-forma to extract information based
on the list required for Cochrane reviews of diagnostic test accu-
racy: sampling, characteristics of participants and setting, index
test, target condition, reference test, flow and timing, use of prior
tests and comparator tests. We will also extract data relating to
study level covariates of average age, proportion of women par-
ticipants, average scores on any cognitive test, stage or severity of
dementia, average educational attainment for participants, aver-
age age and experience of general practitioners performing index
test, and proportion of male and female doctors. We will also ex-
tract study level covariates relating to country of study and type
of practice (categorised as single, group, teaching/academic).
We will extract information relating to the index test based on
what is available in the primary study, which may include both
or either target conditions. There is no accepted cut point for the
index test so we will use the binary classification of whether the
GP judges dementia to be present (index test positive for target
condition dementia) or not (index test negative for target con-
dition dementia), and similarly for cognitive impairment as the
target condition. Where the judgement of the GP is expressed as
a probability we will consider probabilities of 51% and more as
indicating the target condition is considered present (index test
positive). We will extract all the relevant data including, where
reported, results for both all-cause dementia and aetiological sub-
types.
We will contact authors of included primary studies to obtain
missing or unclear information relating to covariates listed above
and/or items on the QUADAS-2 checklist.
Assessment of methodological quality
Two authors will assess study quality using theQUADAS-2 check-
list (Whiting 2011) separately and disagreements will be resolved
by discussion and involvement of an arbitrator if necessary.
Statistical analysis and data synthesis
We will use paired data on sensitivity and specificity to calculate
the accuracy of the index test for diagnosing the two target con-
ditions: cognitive impairment (including both MCI and all-cause
dementia), and all-cause dementia. We will calculate the diagnos-
tic accuracy with 95% confidence intervals separately for each tar-
get condition in all studies with available data.
We will perform meta-analyses on pairs of sensitivity and speci-
ficity, if it is appropriate to pool the data, using the bivariate
random-effects model approach based on pairs of sensitivity and
specificity (Reitsma 2005; Chu 2006; Harbord 2007; Macaskill
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2010). We will use Stata software (StataCorp 2013) to carry out
the additional analyses using the bivariate approach. If it is not
appropriate to perform meta-analysis we will synthesise the re-
sults narratively (Ryan 2013).We will only performmeta-analyses
using all-cause dementia diagnostic criteria (DSM, ICD, Agecat,
CAMDEX, CDR) as this is the target condition that is most ap-
plicable to primary care (rather than aetiological subtypes), and
because in elderly patients there is often mixed pathology. We will
combine different all-cause dementia diagnostic criteria for the
five listed all-cause dementia diagnostic criteria. Expert diagnosis
of all-cause dementia that does not meet one of the listed research
definitions will be meta-analysed separately if appropriate.We will
not perform meta-analyses by aetiological subtype of dementia.
We will also performmeta-analysis with the composite target out-
come of cognitive impairment (including MCI and all-cause de-
mentia). In this analysis true positives will be all cases who are
identified by one of our applicable Reference standards as having
either MCI or all-cause dementia.
If more than one study reports data for the index test (judgement
of GPs) as a probability then we will model this as an implicit
threshold in meta analyses.
Investigations of heterogeneity
We will investigate two sources of heterogeneity: the use of prior
tests or medical records, and the number of diagnostic categories
that are available to GPs in the original study. We consider that
medical records can be conceptualised as a prior test, and that diag-
nostic accuracy might be influenced by whether an original study
offers GPs three possible diagnostic categories (dementia, cogni-
tive impairment, normal) rather than two (cognitive impairment,
normal; or dementia, normal). We will initially investigate hetero-
geneity through visual examination of forest plots - of sensitivities
and specificities - and the ROC plot of the raw data. Where there
is evidence of heterogeneity we will attempt to adjust for this in
the model through inclusion in the hierarchical regression model.
We will use likelihood ratio tests to compare model fit.
We will specifically not include the length of training or type of
training programme as sources of heterogeneity, as we anticipate
these will be poorly reported in original studies and hard to obtain
information if we contact authors. We will not adjust for study
characteristics that are only reported as aggregate measures (e.g.
mean scores of cognitive testing), as it is recommended to only
investigate heterogeneity in diagnostic accuracy by characteristics
that can be assessed at the study level (Bossuyt 2013).
Sensitivity analyses
We will investigate how our estimates of diagnostic accuracy are
modified when we exclude studies that are judged to be at high
risk of bias in more than two domains, or that use extended pri-
mary care follow up or expert clinical judgement as the reference
standard, from the analysis.
Assessment of reporting bias
Quantitative methods for exploring reporting bias are not well
established for studies of DTA (Bossuyt 2013) and so we will not
investigate reporting bias.
A C K N OW L E D G E M E N T S
None
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A D D I T I O N A L T A B L E S
Table 1. Circumstances for contacting authors to obtain information on diagnostic accuracy
Aspect of study that is not relevant to our review Action we will take
Participants Exclude the study
Reference standard Exclude the study
Index test Exclude the study
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Table 1. Circumstances for contacting authors to obtain information on diagnostic accuracy (Continued)
Target condition Contact authors in the hope of obtaining information about diagnostic accu-
racy for target condition of interest only when we are confident from review
of the full text that the participants, reference standard and index test are
applicable to the review
Where studies report the diagnostic accuracy of clinical judgement for the
diagnosis of a composite target condition of cognitive impairment and de-
mentia (e.g. cognitive impairment) we will attempt to obtain details of the
diagnostic accuracy for each of our separate target conditions
Study design Contact authors in the hope of obtaining information about diagnostic accu-
racy for target condition of interest only when we are confident from review
of the full text that the participants, reference standard, index test and target
condition are applicable to the review
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. exp “sensitivity and specificity”/
2. “reproducibility of results”/
3. diagnos*.ti.
4. di.fs.
5. sensitivit*.ab.
6. specificit*.ab.
7. (ROC or “receiver operat*”).ab.
8. Area under curve/
9. (“Area under curve” or AUC).ab.
10. sROC.ab.
11. accura*.ti,ab.
12. (likelihood adj3 (ratio* or function*)).ab.
13. ((true or false) adj3 (positive* or negative*)).ab.
14. ((positive* or negative* or false or true) adj3 rate*).ti,ab
15. or/1-14
16. exp Dementia/
17. Delirium, Dementia, Amnestic, Cognitive Disorders/
18. dement*.mp.
19. alzheimer*.mp.
20. (lewy* adj2 bod*).mp.
21. (chronic adj2 cerebrovascular).mp.
22. (“organic brain disease” or “organic brain syndrome”).mp
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23. (“normal pressure hydrocephalus” and “shunt*”).mp.
24. “benign senescent forgetfulness”.mp.
25. (cerebr* adj2 deteriorat*).mp.
26. (cerebral* adj2 insufficient*).mp.
27. (pick* adj2 disease).mp.
28. (creutzfeldt or jcd or cjd).mp.
29. huntington*.mp.
30. binswanger*.mp.
31. korsako*.mp.
32. “cognit* impair*”.mp.
33. exp *Cognition Disorders/
34. MCI.ti,ab.
35. ACMI.ti,ab.
36. ARCD.ti,ab.
37. SMC.ti,ab.
38. CIND.ti,ab.
39. BSF.ti,ab.
40. AAMI.ti,ab.
41. MD.ti,ab.
42. LCD.ti,ab.
43. QD.ti,ab.
44. AACD.ti,ab.
45. MNCD.ti,ab.
46. MCD.ti,ab.
47. (“N-MCI” or “A-MCI” or “M-MCI”).ti,ab.
48. ((cognit* or memory or cerebr* or mental*) adj3 (declin* or impair* or los* or deteriorat* or degenerat* or complain* or disturb*
or disorder*)).ti,ab
49. “preclinical AD”.mp.
50. “pre-clinical AD”.mp.
51. (“preclinical alzheimer*” or “pre-clinical alzheimer*”).mp
52. (aMCI or MCIa).ti,ab.
53. (“CDR 0.5” or “clinical dementia rating scale 0.5”).ti,ab
54. (“GDS 3” or “stage 3 GDS”).ti,ab.
55. (“global deterioration scale” and “stage 3”).mp.
56. “mild neurocognit* disorder*”.ti,ab.
57. (prodrom* adj2 dement*).ti,ab.
58. (episodic* adj2 memory).mp.
59. (“preclinical dementia” or “pre-clinical dementia”).mp.
60. or/16-59
61. Family Practice/ or Ambulatory Care/
62. Physicians, Family/ or Physicians, Primary Care/
63. Primary Health Care/
64. “family practice”.ti,ab.
65. “general practi*”.ti,ab.
66. *General Practice/ or General Practitioners/
67. “family practices”.ti,ab.
68. “family practitioner*”.ti,ab.
69. “primary care”.ti,ab.
70. Physician Assistants/
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71. “physician assistant*”.ti,ab.
72. Nurse Practitioners/ or Family Nurse Practitioners/
73. “nurse practitioner*”.ti,ab.
74. or/61-73
75. 60 and 74
76. 15 and 75
77. “clinical judgement*”.ti,ab.
78. “practitioner* judgement*”.ti,ab.
79. ((clinician* or GP* or physician* or doctor*) adj3 (intuit* or recognis* or recogniz* or reason* or detect* or diagnos*)).ti,ab
80. “gut feeling*”.ti,ab.
81. gestalt.ti,ab.
82. “GP judgement*”.ti,ab.
83. ((clinician* or GP* or physician* or doctor*) adj3 accura*).ti,ab
84. *Practice Patterns, Physicians’/
85. or/77-84
86. 60 and 85
87. 77 or 86
Appendix 2. Anchoring statements for assessment of risk of bias using QUADAS -2
Selection Index test Reference standard Flow
Was a consecutive or random
sample of patients enrolled? [yes/
no]
Consecutive or random sam-
pling from patients in primary
care would be considered at low
risk of bias
Were the index test results inter-
preted without knowledge of the
results of the reference standard?
[yes/no]
Studies at low risk of bias are
likely to use terms such as
“blinded” or “masked”. Studies
that do not explicitly state that
access to medical records was
deniedwill be judged as unclear.
See Index tests.
Is the reference standard likely to
correctly classify the target condi-
tion? [yes/no]
See Reference standards. We
will only include studies that
use a recognised research defini-
tion of dementia which we will
judge at low risk of bias
Was there an appropriate inter-
val between index test(s) and ref-
erence standard? [yes/no]
A study with an average de-
lay between assessments of six
months or less would be judged
at low risk of bias. A study with
a average delay of more than a
year would be judged at high
risk of bias. For delayed follow
up as a reference standard, fol-
low up should occur at least
threemonths after the index test
assessment
Was a case-control design
avoided? [yes/no]
We will not include case-con-
trol studies.
If a threshold was used, was it pre-
specified? [yes/no]
See Data extraction and
management. There is no ac-
cepted cut point for the index
test. This item is likely to be of
limited value in this review
Were the reference standard re-
sults interpreted without knowl-
edge of the results of the index test?
[yes/no]
Studies at low risk of bias are
likely to use terms such as
“blinded” or “masked”. Stud-
ies that state that the refer-
ence standard assessment was
Did all patients receive a reference
standard? [yes/no]
Many studies in primary care
that are not primarily designed
as prospective research studies
may be at high risk of bias in
this domain. See Index tests.
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(Continued)
allowed knowledge of the index
test will be judged as high risk.
Many studies may be at unclear
risk of bias in this domain be-
cause of the possibility of refer-
ral letters from GPs to special-
ists
Cross-sectional studies may be
at higher risk of bias in this do-
main unless masking is explicit
Did the study avoid inappropri-
ate exclusions? [yes/no]
Example of high risk of bias
would be exclusions based
solely on age, educational at-
tainment or place of residence.
Example of low risk of bias
would be terminally ill people
Did all patients receive the same
reference standard? [yes/no]
It is likely that at least some par-
ticipants will not receive the ref-
erence standard in all studies
Were all patients included in the
analysis?
[yes/no]
Amaximumproportionof drop
outs to remain low risk of bias
has been specified as 20%
Could the selection of patients
have introduced bias? [High/low/
unclear]
If exclusions are not explicit in
the article or after contacting
authors we will judge this as un-
clear
Studie at high risk of bias would
often use a sampling method
that is not consecutive or ran-
dom and / or exclude people in-
appropriately
Could the conduct or interpreta-
tion of the index test have intro-
duced bias?
[High/low/unclear]
see Index tests
Wepropose that the core feature
of clinical judgement is that it is
unaided by any additional test,
investigation or inquiry beyond
that which is immediately avail-
able to the clinician. Provided
that the index testmeets the def-
initionwe use the risk of bias for
this itemmay be low risk. How-
ever, if it is not explicit that no
other brief cognitive tests were
used then the item may be at
unclear risk of bias
Could the reference standard, its
conduct, or its interpretation have
introduced bias?
[High/low/unclear]
Even allowing for an acceptable
reference standard studies may
often be at unclear risk of bias
in this domain unless it is ex-
plicit that the reference stan-
dard was applied independently
of the index test
Could the patient flow have in-
troduced bias? High/low/unclear]
Many studies that are not
primarily designed as research
studies are likely to be at high
risk of bias in this domain
Are there concerns that the in-
cluded patients do not match the
review question?
Are there concerns that the index
test, its conduct, or interpretation
differ from the review question?
Are there concerns that the target
condition as defined by the refer-
ence standard does not match the
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(Continued)
Studies with high applicability
will commonly include frail el-
derly people with multi-mor-
bidity. Studies with low applica-
bility will exclude these people.
Studies with a prevalence of de-
mentia of more than 70% will
often be of low applicability
see Index tests. So long as the
clinical judgement about de-
mentia has been made by a pri-
mary care physician / general
practitioner we will judge this
at high applicability
review question?
So long as the reference stan-
dard is one of our listed defini-
tions we will judge this at high
applicability
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